Perbedaan Woori Finance Indonesia Tbk dan Brigit Biofarmaka Teknologi Tbk.: Woori Finance Indonesia Tbk diperdagangkan di Rp254 (kapitalisasi pasar 700,59 M, volume 24 jam 169,1 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp242 (kapitalisasi pasar 164,65 M, volume 24 jam 177,8 rb). Perbedaan utamanya: Woori Finance Indonesia Tbk jauh lebih besar — sekitar 4,3× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Brigit Biofarmaka Teknologi Tbk. lebih aktif diperdagangkan (177,8 rb vs 169,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BPFI | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 700,59 M | 164,65 M |
Volume | 169,1 rb | 177,8 rb |
Lot | 1,69 rb | 1,78 rb |
Perputaran | 42,52 jt | 42,05 jt |
Harga Rata-rata | 251,45 | 236,47 |
Nilai Transaksi | 42,52 jt | 42,05 jt |
Harga Ekuilibrium Indikatif | 262 | 242 |
Volume Ekuilibrium Indikatif | 5 rb | 500 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Batavia Prosperindo Finance Tbk (the Company) was established under its original name of Bira Multi Finance on Dec 12, 1994 then changed to PT Batavia Prosperindo Finance based on Notaries Deed dated Apr 18, 2008. The deed of establishment was approved by the the Ministry of Justice dated Apr 4, 2007.
Selengkapnya di halaman BPFI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →